NWRD09 for HPV-16 Related Cervical HSIL

Clinical trial NCT07047989 · RECRUITING

Trial details

NCT number: NCT07047989
Sponsor: Newish Biotech (Wuxi) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High-grade Squamous Intraepithelial Lesion (HSIL)

Start date: 2025-06-12
Primary completion: 2026-07-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.